Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA, and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and also through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Qiagen NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Qiagen NV Company Overview
- Qiagen NV Company Snapshot
- Qiagen NV Pipeline Products and Ongoing Clinical Trials Overview
- Qiagen NV - Pipeline Analysis Overview
- Business Description
- Qiagen NV - Key Facts
- Qiagen NV - Major Products and Services
- Qiagen NV Pipeline Products by Development Stage
- Qiagen NV Ongoing Clinical Trials by Trial Status
- Qiagen NV Pipeline Products Overview
- Access Anti-SARS-CoV-2 Antigen Test
- Access Anti-SARS-CoV-2 Antigen Test Product Overview
- Access Anti-SARS-CoV-2 Antigen Test - Lab Use
- Access Anti-SARS-CoV-2 Antigen Test - Lab Use Product Overview
- Access Anti-SARS-CoV-2 Total Serology Test
- Access Anti-SARS-CoV-2 Total Serology Test Product Overview
- AR-V7 Companion Diagnostic Test
- AR-V7 Companion Diagnostic Test Product Overview
- artus SARS-CoV-2 Prep&Amp UM Kit
- artus SARS-CoV-2 Prep&Amp UM Kit Product Overview
- Blood Based Test - Colorectal Cancer
- Blood Based Test - Colorectal Cancer Product Overview
- Care CT
- Care CT Product Overview
- Care CT/NG
- Care CT/NG Product Overview
- Care NG
- Care NG Product Overview
- Care TV
- Care TV Product Overview
- CDx Assay - Acute Myeloid Leukemia
- CDx Assay - Acute Myeloid Leukemia Product Overview
- CDx Diagnostic Kit - pan-NTRK
- CDx Diagnostic Kit - pan-NTRK Product Overview
- Companion Diagnostic - TCR/BCR Assay
- Companion Diagnostic - TCR/BCR Assay Product Overview
- Companion Diagnostic Assay - EGFR vIII
- Companion Diagnostic Assay - EGFR vIII Product Overview
- Companion Diagnostic Assay - MGCD265
- Companion Diagnostic Assay - MGCD265 Product Overview
- Companion Diagnostic Assay - Oncology
- Companion Diagnostic Assay - Oncology Product Overview
- Companion Diagnostic Assay - Parkinson's Disease
- Companion Diagnostic Assay - Parkinson's Disease Product Overview
- Companion Diagnostic Assay - Precancerous Cervical Lesions
- Companion Diagnostic Assay - Precancerous Cervical Lesions Product Overview
- Companion Diagnostic Test - ASP5878
- Companion Diagnostic Test - ASP5878 Product Overview
- Companion Diagnostic Test - ASP8273
- Companion Diagnostic Test - ASP8273 Product Overview
- Companion Diagnostic Test - Binimetinib
- Companion Diagnostic Test - Binimetinib Product Overview
- Companion Diagnostic Test - BNT113
- Companion Diagnostic Test - BNT113 Product Overview
- Companion Diagnostic Test - Diffuse Large B Cell Lymphoma
- Companion Diagnostic Test - Diffuse Large B Cell Lymphoma Product Overview
- Companion Diagnostic Test - EZH2 Y641
- Companion Diagnostic Test - EZH2 Y641 Product Overview
- Companion Diagnostic Test - FGFR-TACC
- Companion Diagnostic Test - FGFR-TACC Product Overview
- Companion Diagnostic Test - IDH1/IDH2 Gene
- Companion Diagnostic Test - IDH1/IDH2 Gene Product Overview
- Diagnostic Test - Stage III And IV Colon Cancer
- Diagnostic Test - Stage III And IV Colon Cancer Product Overview
- Diagnostic Test - T-Cell Lymphoma
- Diagnostic Test - T-Cell Lymphoma Product Overview
- GeneRead QIAact Lung All-in-One Assay
- GeneRead QIAact Lung All-in-One Assay Product Overview
- GeneReader NGS System - BRCA Liquid Biopsy Assay
- GeneReader NGS System - BRCA Liquid Biopsy Assay Product Overview
- GeneReader NGS System - Infectious Diseases
- GeneReader NGS System - Infectious Diseases Product Overview
- GeneReader NGS System - Leukemia
- GeneReader NGS System - Leukemia Product Overview
- GeneReader NGS System - MPN
- GeneReader NGS System - MPN Product Overview
- Genetic Test - Prostate Cancer
- Genetic Test - Prostate Cancer Product Overview
- miRNA Biomarker - Cancer of Unknown Primary
- miRNA Biomarker - Cancer of Unknown Primary Product Overview
- miRNA Test - Endometrial Cancer
- miRNA Test - Endometrial Cancer Product Overview
- miRNA Test - Lung Cancer
- miRNA Test - Lung Cancer Product Overview
- miRNA Test - Ovarian Cancer
- miRNA Test - Ovarian Cancer Product Overview
- mSEPT9 Colorectal Cancer Test
- mSEPT9 Colorectal Cancer Test Product Overview
- NeuMoDx - VZV
- NeuMoDx - VZV Product Overview
- NeuMoDx 288 - Parasitic And Hospital Acquired Infections Assay
- NeuMoDx 288 - Parasitic And Hospital Acquired Infections Assay Product Overview
- NeuMoDx 288 - Post-Transplant Infections Assay
- NeuMoDx 288 - Post-Transplant Infections Assay Product Overview
- NeuMoDx 288 - Respiratory Infections Assay
- NeuMoDx 288 - Respiratory Infections Assay Product Overview
- NeuMoDx 288 Molecular System - EBV 2.0 Assay
- NeuMoDx 288 Molecular System - EBV 2.0 Assay Product Overview
- NeuMoDx 288 Molecular System - GBS Assay
- NeuMoDx 288 Molecular System - GBS Assay Product Overview
- NeuMoDx 288 Molecular System - HBV Assay
- NeuMoDx 288 Molecular System - HBV Assay Product Overview
- NeuMoDx 288 Molecular System - HCV Assay
- NeuMoDx 288 Molecular System - HCV Assay Product Overview
- NeuMoDx 500 Molecular IVD System
- NeuMoDx 500 Molecular IVD System Product Overview
- NeuMoDx 96 - Parasitic And Hospital Acquired Infections Assay
- NeuMoDx 96 - Parasitic And Hospital Acquired Infections Assay Product Overview
- NeuMoDx 96 - Post-Transplant Infections Assay
- NeuMoDx 96 - Post-Transplant Infections Assay Product Overview
- NeuMoDx 96 - Respiratory Infections Assay
- NeuMoDx 96 - Respiratory Infections Assay Product Overview
- NeuMoDx Assay - MG Resistance
- NeuMoDx Assay - MG Resistance Product Overview
- NeuMoDx CMV Assay
- NeuMoDx CMV Assay Product Overview
- NeuMoDx CT/NG Assay
- NeuMoDx CT/NG Assay Product Overview
- NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test
- NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Product Overview
- NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Clinical Trial
- NeuMoDx HIV Assay
- NeuMoDx HIV Assay Product Overview
- NeuMoDx MPXV Test Strip
- NeuMoDx MPXV Test Strip Product Overview
- NeuMoDx SARS-CoV-2 Assay
- NeuMoDx SARS-CoV-2 Assay Product Overview
- Prognosis Test - Prostate Cancer
- Prognosis Test - Prostate Cancer Product Overview
- QIAact Breast Panel (Expanded)
- QIAact Breast Panel (Expanded) Product Overview
- QIAact Gene Expression Signatures
- QIAact Gene Expression Signatures Product Overview
- QIAact Lung Panel (CNV And Fusion)
- QIAact Lung Panel (CNV And Fusion) Product Overview
- QIAact Onco-Heme Panel - Myeloid
- QIAact Onco-Heme Panel - Myeloid Product Overview
- QIAcuity dPCR System
- QIAcuity dPCR System Product Overview
- QIAensemble 400 - Bacterial Vaginosis
- QIAensemble 400 - Bacterial Vaginosis Product Overview
- QIAensemble 400 - Candida Species
- QIAensemble 400 - Candida Species Product Overview
- QIAensemble 400 - Chlamydia Trachomatis/Neisseria Gonorrhea
- QIAensemble 400 - Chlamydia Trachomatis/Neisseria Gonorrhea Product Overview
- QIAensemble 400 - Group B Streptococci
- QIAensemble 400 - Group B Streptococci Product Overview
- QIAensemble 400 - Herpes Simplex Virus 1 and 2
- QIAensemble 400 - Herpes Simplex Virus 1 and 2 Product Overview
- QIAensemble 400 - Trichomonas Vaginalis
- QIAensemble 400 - Trichomonas Vaginalis Product Overview
- QIAensemble SP/2000 With Screening And Genotyping
- QIAensemble SP/2000 With Screening And Genotyping Product Overview
- QIAprep& Viral RNA UM Kit
- QIAprep& Viral RNA UM Kit Product Overview
- QIAreach Anti-SARS-CoV-2 Total Test
- QIAreach Anti-SARS-CoV-2 Total Test Product Overview
- QIAreach SARS-CoV-2 Antigen Test - Lab Use
- QIAreach SARS-CoV-2 Antigen Test - Lab Use Product Overview
- QIAreach SARS-CoV-2 Antigen Test - POC
- QIAreach SARS-CoV-2 Antigen Test - POC Product Overview
- QIAstat-Dx Gastrointestinal Panel
- QIAstat-Dx Gastrointestinal Panel Product Overview
- QIAstat-Dx High-Throughput Tower
- QIAstat-Dx High-Throughput Tower Product Overview
- QIAstat-Dx Meningitis Test
- QIAstat-Dx Meningitis Test Product Overview
- QIAstat-Dx Pneumonia Panel
- QIAstat-Dx Pneumonia Panel Product Overview
- QIAstat-Dx Positive Blood Culture
- QIAstat-Dx Positive Blood Culture Product Overview
- QIAstat-Dx Respiratory SARS-CoV-2 Panel
- QIAstat-Dx Respiratory SARS-CoV-2 Panel Product Overview
- QIAstat-Dx Respiratory SARS-CoV-2 Panel Clinical Trial
- QIAstat-Dx Rise
- QIAstat-Dx Rise Product Overview
- QIAstat-Dx System - Oncology Assay 1
- QIAstat-Dx System - Oncology Assay Product Overview 1
- QIAstat-Dx
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hologic Inc
- Promega Corp
- Roche Diagnostics International Ltd
- MilliporeSigma
- 2invest AG
